Evidence map›Paper›PMID 29937994›Full record

ArticleOncotarget2018

The landscape of somatic mutation in sporadic Chinese colorectal cancer.

Zhe Liu, Chao Yang, Xiangchun Li, Wen Luo, Bhaskar Roy, Teng Xiong, Xiuqing Zhang, Huanming Yang, Jian Wang, Zhenhao Ye and 7 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 1 country.

Zhe Liu *Beijing Anzhen Hospital, Capital Medical University, The Key Laboratory of Remodeling-Related Cardiovascular Diseases, Ministry of Education, Beijing Collaborative Innovation Center for Cardiovascular Disorders, Beijing Institute of Heart, Lung and Blood Vessel Disease, Beijing, China.
Chao Yang *BGI Genomics, BGI-Shenzhen, Shenzhen, China.
Xiangchun LiBGI Genomics, BGI-Shenzhen, Shenzhen, China.
Wen LuoBGI Genomics, BGI-Shenzhen, Shenzhen, China.
Bhaskar RoyBGI Genomics, BGI-Shenzhen, Shenzhen, China.
Teng XiongBGI Genomics, BGI-Shenzhen, Shenzhen, China.
Xiuqing ZhangBGI Genomics, BGI-Shenzhen, Shenzhen, China.
Huanming YangBGI Genomics, BGI-Shenzhen, Shenzhen, China.
Jian WangBGI Genomics, BGI-Shenzhen, Shenzhen, China.
Zhenhao YeThe Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Yang ChenThe Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Jinghe SongSKLSDE Lab, Beihang University, Beijing, China.
Shuai MaSKLSDE Lab, Beihang University, Beijing, China.
Yong ZhouBGI Genomics, BGI-Shenzhen, Shenzhen, China.
Min YangBeijing Anzhen Hospital, Capital Medical University, The Key Laboratory of Remodeling-Related Cardiovascular Diseases, Ministry of Education, Beijing Collaborative Innovation Center for Cardiovascular Disorders, Beijing Institute of Heart, Lung and Blood Vessel Disease, Beijing, China.
Xiaodong FangBGI Genomics, BGI-Shenzhen, Shenzhen, China.
Jie DuBeijing Anzhen Hospital, Capital Medical University, The Key Laboratory of Remodeling-Related Cardiovascular Diseases, Ministry of Education, Beijing Collaborative Innovation Center for Cardiovascular Disorders, Beijing Institute of Heart, Lung and Blood Vessel Disease, Beijing, China.
BGI GenomicsBGI Group (China) · CNBeihang University · CNCapital Medical University · CNGuangzhou University of Chinese Medicine · CNBeijing Anzhen Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer is the fifth prevalent cancer in China. Nevertheless, a large-scale characterization of Chinese colorectal cancer mutation spectrum has not been carried out. In this study, we have performed whole exome-sequencing analysis of 98 patients' tumor samples with matched pairs of normal colon tissues using Illumina and Complete Genomics high-throughput sequencing platforms. Canonical CRC somatic gene mutations with high prevalence (>10%) have been verified, including

Indexed as

Chinese patientscolorectal cancerdisease etiologymutation spectrumwhole-exome sequencing

Identifiers

PMID29937994
PMCPMC6007951
OpenAlexW2949202382

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.